BMC cancer

Contentshow allhide all

1. 2023

   • Vol. 23: Analysis of connexin 43, connexin 45 and N-cadherin in the human sertoli cell line FS1 and the human seminoma-like cell line TCam-2 in comparison with human testicular biopsies

     Schulz, Birte; Schumacher, Valérie; Ngezahayo, Anaclet; Maier-Begandt, Daniela; Schadzek, Nadine; Wilhelm, Jochen; Weidner, Wolfgang; Pilatz, Adrian; Fietz, Daniela; Kliesch, Sabine; Schnepel, Nadine; Hambruch, Nina; Rode, Kristina; Langeheine, Marion; Brehm, Ralph
2. 2021

   • Vol. 21: Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line

     Weiner, Franziska; Schille, Jan Torben; Koczan, D.; Wu, X.-F.; Beller, M.; Junghanss, C.; Hewicker-Trautwein, Marion; Murua Escobar, Hugo; Nolte, Ingo